REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON ORAL CORTICOSTEROID USE IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA

被引：0
|
作者：
Pawar, A.
Blaiss, M.
Modena, B.
Khan, A.
DePrado-Gomez, L.
Pandit-Abid, N.
Radwan, A.
Jacob-Nara, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P115
引用
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [1] Real-world Effectiveness of Dupilumab on Oral Corticosteroid Use and Asthma Exacerbations in Patients With Moderate-to-Severe Asthma
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A.
    De Prado Gomez, L.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] REAL-WORLD REDUCTION OF ORAL CORTICOSTEROID USE IN PATIENTS TREATED WITH DUPILUMAB AND WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. D. P.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [3] Real-world effectiveness of dupilumab on oral corticosteroid use in asthma
    Wark, P.
    Pawar, A.
    Blaiss, M.
    Modena, B.
    Khan, A.
    Gomez, De Prado L.
    Pandit-Abid, N.
    Radwan, A.
    Moody, J.
    Jacob-Nara, J.
    [J]. RESPIROLOGY, 2023, 28 : 87 - 88
  • [4] A real-world study of symptomatic eosinophilia in moderate-to-severe asthma patients on dupilumab therapy
    Fisch, Matthew
    Fajt, Merritt L.
    Wenzel, Sally E.
    Petrov, Andrej A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08): : 2183 - 2186
  • [5] Dupilumab Real-world Effectiveness (RWE) in Reducing Healthcare Resource Utilization Among Moderate-to-Severe Asthma Patients
    Modena, B. D.
    Pawar, A.
    Blaiss, M. S.
    Khan, A.
    Gomez, L. De Prado
    Zhang, Y.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Real-world effectiveness (RWE) of dupilumab in reducing healthcare resource utilization among moderate-to-severe asthma patients
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. De Prado
    Zhang, Y.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Gomez, L. De Prado
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] The RAPID Registry: A Global Real-World Cohort of Patients Receiving Dupilumab for the Treatment of Moderate-to-Severe Asthma
    Jain, N.
    Soong, W.
    Settipane, R. A.
    Gall, R.
    Zhen, C.
    Zhang, Y.
    Tmirah, H.
    Jacob-Nara, J. A.
    Ortiz, B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [8] Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study
    Numata, Takanori
    Araya, Jun
    Miyagawa, Hanae
    Okuda, Keitaro
    Takekoshi, Daisuke
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Kuwano, Kazuyoshi
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 395 - 405
  • [9] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
  • [10] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
12345